// App-Quantinova.ai

OC 14.2 : Long-term outcomes of superficial vein thrombosis in daily practice: 12-month data from the INSIGHTS-SVT study

Researchers

Presenter

  • E. Rabe

Principal Investigators

  • U. Hoffmann

  • F. Langer

  • D. Pittrow

  • J. Klotsche

  • R. Bauersachs

Medical Centers

  • University Clinic Bonn, Bonn, Nordrhein-Westfalen, Germany

  • Ludwig-Maximilians-University, Munich, Bayern, Germany

  • Mylan Pharmaceuticals GmbH, Bad Homburg, Hessen, Germany

  • Aspen GmbH, Munich, Bayern, Germany

  • II. Medizinische Klinik und Poliklinik, Zentrum für Onkologie, UKE, Hamburg, Germany, Hamburg, Hamburg, Germany

  • Martha-Maria Hospital Nuremberg, Nuremberg, Bayern, Germany

  • Institute for Clinical Pharmacology, Dresden, Germany

  • German Rheumatism Research Centre, Berlin, Germany

  • Office for Vascular Diseases, Mannheim, Hessen, Germany

  • Standort AGAPLESION Bethanien Krankenhaus, Frankfurt, Hessen, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Angiology

  • Blood/haematological Diseases

Disease

  • Superficial Vein Thrombosis

  • Deep vein thrombosis

  • Pulmonary embolism

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Observational

  • Prospective

Phase

  • NA

Study Id's

  • NCT02699151

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved